Keyword

ozanimod

Description: Ozanimod is an oral sphingosine 1-phosphate receptor modulator used to treat relapsing multiple sclerosis and ulcerative colitis.
Wikidata ID: wiki/Q21098986
OpenAlex ID: keywords/ozanimod
2023 · Beatriz Gros, Gilaad G. Kaplan · JAMA · 861
2021 · William J. Sandborn, Brian G. Feagan, et al. · New England Journal of Medicine · 647
2016 · William J. Sandborn, Brian G. Feagan, et al. · New England Journal of Medicine · 483
2021 · Marisa P McGinley, Jeffrey A Cohen · The Lancet · 341
2021 · Tamara Pérez-Jeldres, Manuel Alvarez-Lobos, et al. · Drugs · 217
2018 · Bram Verstockt, Marc Ferrante, et al. · Journal of Gastroenterology · 190
2017 · Laurent Peyrin-Biroulet, Ronald Christopher, et al. · Autoimmunity Reviews · 164
2015 · Adnan M. Subei, Jeffrey A. Cohen · CNS Drugs · 162
2020 · Brian G Feagan, William J Sandborn, et al. · The Lancet. Gastroenterology & hepatology · 149
2017 · Burhan Z. Chaudhry, Jeffrey A. Cohen, et al. · Neurotherapeutics · 149
2019 · Tamara Pérez-Jeldres, Christopher J. Tyler, et al. · Frontiers in Pharmacology · 131
2021 · Imtiaz A Samjoo, Evelyn Worthington, et al. · Journal of Comparative Effectiveness Research · 128
2022 · Virginia Solitano, Antonio Facciorusso, et al. · Clinical Gastroenterology and Hepatology · 127
2020 · Tobias Derfuss, Matthias Mehling, et al. · The Lancet Neurology · 124
2020 · Yvette N. Lamb · Drugs · 120
2017 · Jonathan Q. Tran, Jeffrey P. Hartung, et al. · The Journal of Clinical Pharmacology · 116
Works count: 819
Citation count: 11,190
Year
Topic
Type